340B Drug Pricing Program
AHA provides feedback on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act) discussion draft.
The AHA today submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act).
Reminder: Submit comments on calendar year 2027 outpatient prospective payment system proposed rule by Aug. 31.
The AHA's principal recommendation is that CMS use its authority to require drug manufacturers to make the Maximum Fair Price (MFP) available through a prospective, point-of-sale mechanism and eliminate any option that would permit manufacturers to satisfy their obligations through retrospective…
The AHA Aug. 12 at 3 p.m. ET will host a call for 340B hospitals to discuss several aspects of the 340B Drug Pricing Program, including the rebate model and congressional activities.
On Jan. 15, Eli Lilly & Company (Lilly) announced that starting Feb. 1 it will require all 340B covered entities to submit claims-level data (CLD) for all dispenses of Lilly drugs, regardless of setting.
Sens. Jerry Moran, R-Kan., Tammy Baldwin, D-Wis., Shelley Moore Capito, R-W.Va., Tim Kaine, D-Va., John Boozman, R-Ark., and John Hickenlooper, D-Colo., introduced the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act or SUSTAIN…
The AHA today issued a Legislative Advisory that includes a detailed summary of the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act or SUSTAIN 340B Act.
The AHA today issued a Regulatory Advisory that includes a detailed summary of the Health Resources and Services Administration announcement on the new 340B Rebate Model Program
The 340B Drug Pricing Program was established by Congress to ensure that hospitals serving low-income, rural and medically underserved communities are able to stretch limited federal resources and use their savings to maintain, improve and expand access to care.